Please login to the form below

Not currently logged in
Email:
Password:

CNS

This page shows the latest CNS news and features for those working in and with pharma, biotech and healthcare.

Latest news

More from news
Approximately 4 fully matching, plus 164 partially matching documents found.

Latest Intelligence

  • A quest for innovative solutions A quest for innovative solutions

    PRISM has matured into an artery of new opportunities such as its collaboration on RADAR-CNS (Remote Assessment of Disease and Relapse - Central Nervous System), an initiative that aims to develop

  • The good, the bad and the ugly The good, the bad and the ugly

    Pfizer has large sales in CNS - $8.5bn in 2017. The majority come through Lyrica ($5bn). ... In Europe, a patent dispute over Lyrica became arguably the biggest CNS story in recent years.

  • Pharma deals continue to slide Pharma deals continue to slide

    1, 410 (upfront 80). WuXi Biologics and Gloria Pharma (CN). Arcus Biosciences (US). ... 163. Mologen (DE). iPharma (CN). Binding term sheet for licensing and co-development.

  • Deal Watch - May 2017 Deal Watch - May 2017

    Peptidream (CN). Janssen (US). Licence. Peptide discovery platform. Up to 1, 150.

  • Deal Watch September 2016 Deal Watch September 2016

    210. Ligand / Seelos. Licence. 4 programmes including aplindore for CNS disorders.

More from intelligence
Approximately 0 fully matching, plus 38 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 25 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CMR

Specialising in medical device market research, our approach is people-centric and we thrive on making connections with clients and research...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics